Barbara Tettenborn
Research Subjects
Barbara Tettenborn has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Bernhard J. Steinhoff
Epilepsy Center Kork Kehl‐Kork Germany
1 shared publication - Bettina Schmitz
Vivantes Humboldt-Klinikum
1 shared publication - Bettina Schmitz
Stroke Unit, Clinic for Neurology, Epilepsy Center Vivantes‐Humboldt Clinic Berlin Germany
1 shared publication - Christoph Baumgartner
Department of Neurology, Clinic Hietzing, Vienna
1 shared publication Dominique Flügel
Department of Neurology Cantonal Hospital St. Gallen St. Gallen Switzerland
1 shared publication- Eckhard Bonmann1 shared publication
Latest Publications
- 1 January 2027
- Published by Georg Thieme Verlag KG
Epilepsie
- 1 January 2027
- Published by Georg Thieme Verlag KG
Diagnostische Verfahren in der Neurologie
- 18 September 2026
- Published by Springer Nature in DGNeurologie
- Vol. 9 (7) , 563-566
Sportneurologie
- Top Cited PapersOpen Access
Women with epilepsy: Evidence‐based counseling across the lifespan
Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex‐specific aspects of epilepsy has increased, important gaps remain in their integration into routine care. This review synthesizes current evidence on epilepsy management across key life stages, including adolescence and transition to adult care, reproductive health, contraception, fertility and pregnancy, lactation, menopause, and bone health. It integrates recent literature with expert interpretation in alignment with contemporary clinical guidelines, with the aim of enhancing clinical applicability. Hormonal changes, bidirectional interactions between antiseizure medications (ASMs), and reproductive physiology as well as shifting psychosocial demands influence seizure patterns, treatment efficacy, and long‐term health outcomes in WWE. Particular focus is placed on interactions between epilepsy, endocrine regulation, and ASM therapy, and on teratogenic and neurodevelopmental risks associated with specific ASMs. Effective care for WWE requires continuous, individualized counseling that adapts to changing priorities and risks over time. Structured transition processes, evidence‐based counseling on contraception and pregnancy, therapeutic drug monitoring during pregnancy, and transparent communication regarding fetal risks of ASMs are essential components of high‐quality care. Beyond the reproductive years, seizure changes during menopause and the cumulative impact of long‐term ASM exposure, particularly on bone health, require surveillance and prevention. Despite advances in pregnancy registries and treatment recommendations, participation in registries is low, and evidence outside pregnancy remains limited. Awareness of sex‐specific epilepsy issues continues to be insufficient among both WWE and health care professionals. Addressing these gaps will require improved education, coordinated multidisciplinary care, and expanded research efforts to support patient‐centered, lifelong care for WWE.
Top Cited PapersOpen AccessWomen with epilepsy: Evidence‐based counseling across the lifespan
Women with epilepsy (WWE) encounter distinct and evolving challenges across the lifespan that require clinical management extending beyond seizure control alone. Although awareness of sex‐specific aspects of epilepsy has increased, important gaps remain in their integration into routine care. This review synthesizes current evidence on epilepsy management across key life stages, including adolescence and transition to adult care, reproductive health, contraception, fertility and pregnancy, lactation, menopause, and bone health. It integrates recent literature with expert interpretation in alignment with contemporary clinical guidelines, with the aim of enhancing clinical applicability. Hormonal changes, bidirectional interactions between antiseizure medications (ASMs), and reproductive physiology as well as shifting psychosocial demands influence seizure patterns, treatment efficacy, and long‐term health outcomes in WWE. Particular focus is placed on interactions between epilepsy, endocrine regulation, and ASM therapy, and on teratogenic and neurodevelopmental risks associated with specific ASMs. Effective care for WWE requires continuous, individualized counseling that adapts to changing priorities and risks over time. Structured transition processes, evidence‐based counseling on contraception and pregnancy, therapeutic drug monitoring during pregnancy, and transparent communication regarding fetal risks of ASMs are essential components of high‐quality care. Beyond the reproductive years, seizure changes during menopause and the cumulative impact of long‐term ASM exposure, particularly on bone health, require surveillance and prevention. Despite advances in pregnancy registries and treatment recommendations, participation in registries is low, and evidence outside pregnancy remains limited. Awareness of sex‐specific epilepsy issues continues to be insufficient among both WWE and health care professionals. Addressing these gaps will require improved education, coordinated multidisciplinary care, and expanded research efforts to support patient‐centered, lifelong care for WWE.
- Open Access
- 1 November 2023
- Published by Springer Nature in Clinical Epileptology
- Vol. 36 (S2) , 115-119
Does SANAD II help with gender-specific problems in epilepsy treatment?—English Version
- 1 November 2023
- Published by Springer Nature in Clinical Epileptology
- Vol. 36 (S2) , 115-119
Open AccessDoes SANAD II help with gender-specific problems in epilepsy treatment?—English Version
- Open Access
- 1 August 2023
- Published by Springer Nature in Clinical Epileptology
- Vol. 36 (3) , 190-191
Gender-specific aspects in epileptology
- 1 August 2023
- Published by Springer Nature in Clinical Epileptology
- Vol. 36 (3) , 190-191
Open AccessGender-specific aspects in epileptology
- Open Access
- 1 January 2021
- Published by MDPI AG in Clinical and Translational Neuroscience
- Vol. 5 (1)
Stroke in women: Is it different?
In the last decades, there has been great progress in the field of stroke. With the introduction of acute therapies (intravenous thrombolysis and intra-arterial treatment), the outcome after stroke has improved significantly. Better prevention, improved acute therapy, and acute rehabilitation improved the morbidity and mortality rate after stroke. Gender differences in risk factors and epidemiology have been known for a long time, but lately attention to gender differences in stroke has increased. The aim of this mini-review is to demonstrate gender disparities in stroke with a focus on epidemiology, specific risk factors (gender-specific and unspecific), and outcomes. The influence of some risk factors for stroke is stronger in women (atrial fibrillation and hypertension) and there are risk factors exclusive to women such as pregnancy, pregnancy-associated hypertensive disorders, oral contraceptives, and hormonal replacement treatment. Data on the impact of other risk factors are inconsistent. The worse outcome after a stroke is mainly caused by demographic characteristics in women. Specific gender research is needed to better understand gender disparities in stroke to improve prevention strategies and treatment for women.
- 1 January 2021
- Published by MDPI AG in Clinical and Translational Neuroscience
- Vol. 5 (1)
Open AccessStroke in women: Is it different?
In the last decades, there has been great progress in the field of stroke. With the introduction of acute therapies (intravenous thrombolysis and intra-arterial treatment), the outcome after stroke has improved significantly. Better prevention, improved acute therapy, and acute rehabilitation improved the morbidity and mortality rate after stroke. Gender differences in risk factors and epidemiology have been known for a long time, but lately attention to gender differences in stroke has increased. The aim of this mini-review is to demonstrate gender disparities in stroke with a focus on epidemiology, specific risk factors (gender-specific and unspecific), and outcomes. The influence of some risk factors for stroke is stronger in women (atrial fibrillation and hypertension) and there are risk factors exclusive to women such as pregnancy, pregnancy-associated hypertensive disorders, oral contraceptives, and hormonal replacement treatment. Data on the impact of other risk factors are inconsistent. The worse outcome after a stroke is mainly caused by demographic characteristics in women. Specific gender research is needed to better understand gender disparities in stroke to improve prevention strategies and treatment for women.
- Open Access
- 1 May 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (5) , 395-396
The SeLECT score is useful to predict post-stroke epilepsy
- 1 May 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (5) , 395-396
Open AccessThe SeLECT score is useful to predict post-stroke epilepsy
- 1 January 1995
- Published by Springer Nature
- p. 473-481
Polytopiekriterien in der Diagnostik von Hirnstammläsionen
- 1 January 1995
- Published by Springer Nature
- p. 473-481
Polytopiekriterien in der Diagnostik von Hirnstammläsionen